RPL24: a potential therapeutic target whose depletion or acetylation inhibits polysome assembly and cancer cell growth

Kathleen A. Wilson-Edell(Buck Institute for Research on Aging), Christopher C. Benz(University of California, San Francisco)
Oncotarget
June 12, 2014
Cited by 52


Related Papers